SCHEMBL4846900

SCHEMBL4846900

NC(=O)Cc1cccc2cc(CN3CCCCC3)ccc12

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 1/20 0.48
HIF1A Q16665 1/20 0.48
PARP1 P09874 4/20 0.44
PARP2 Q9UGN5 2/20 0.44
PARP3 Q9Y6F1 2/20 0.44
SIGMAR1 Q99720 1/20 0.44
PRMT6 Q96LA8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MC4R P32245 1/20 0.42
MC5R P33032 1/20 0.42
CYP2C19 P33261 1/20 0.42
HRH3 Q9Y5N1 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CHEK1 O14757 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4840236 0.99 CYP2D6 (0.46) CYP2D6CYP2C9HIF1APARP1PARP2
SCHEMBL4850572 0.83 PRMT6 (0.56) CYP2D6PRMT6SMN1; SMN2TDP1ALDH1A1
SCHEMBL4850567 0.82 PARP1 (0.57) CYP2D6CYP2C9HIF1APARP1PARP2
SCHEMBL4844432 0.81 PRMT6 (0.58) CYP2D6PRMT6SMN1; SMN2TDP1ALDH1A1
SCHEMBL4844426 0.81 PARP1 (0.56) CYP2D6CYP2C9HIF1APARP1PARP2
SCHEMBL4846907 0.77 NCF1 (0.54) CYP2D6PRMT6SMN1; SMN2TDP1ALDH1A1
SCHEMBL28610633 0.77 PRMT6 (0.63) CYP2D6CYP2C9HIF1APARP1PRMT6
SCHEMBL4846896 0.77 SMN1; SMN2 (0.42) CYP2D6CYP2C9HIF1APRMT6SMN1; SMN2
SCHEMBL4839412 0.76 KMT2A (0.51) SIGMAR1PRMT6MC4RMC5RMEN1
SCHEMBL4840245 0.75 NCF1 (0.55) CYP2D6PRMT6SMN1; SMN2TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368462-B1 Melanin concentrating hormone antagonists THE PROCTER & GAMBLE COMPANY (US) 2008-05-06 US claimed
US-7368462-B1 Melanin concentrating hormone antagonists THE PROCTER & GAMBLE COMPANY (US) 2008-05-06 US disclosed
US-20080058423-A1 Melanin concentrating hormone antagonists THE PROCTER & GAMBLE COMPANY 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058423-A1 Melanin concentrating hormone antagonists MCHR1, MCHR2, MC4R CYP2D6 1658/4885CYP2C9 3090/4885HIF1A 1532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.